Scleroderma Trials in Ann Arbor, United States
Conditions / Scleroderma / Ann Arbor, United States
Clinical trials for Scleroderma investigate a range of treatment strategies and patient populations.
24 total trials for this combination
Showing top 10 of 24 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00930683 | A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma | COMPLETED | PHASE1 |
| NCT06843239 | Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) | RECRUITING | PHASE2 |
| NCT05925803 | Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00377949 | Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients | COMPLETED | — |
| NCT06195072 | Platform Clinical Study for Conquering Scleroderma | RECRUITING | PHASE2 |
| NCT03222492 | Brentuximab Vedotin for Systemic Sclerosis | COMPLETED | PHASE1/PHASE2 |
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | COMPLETED | PHASE2 |
| NCT06328777 | RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis | RECRUITING | — |
| NCT00883129 | Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) | COMPLETED | PHASE2 |
| NCT00764309 | Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis | COMPLETED | PHASE1/PHASE2 |